Oramed Pharmaceuticals
ORMP
ORMP
39 hedge funds and large institutions have $6.18M invested in Oramed Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 5 increasing their positions, 9 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
2.36% less ownership
Funds ownership: 8.52% → 6.15% (-2.4%)
44% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 9
Holders
39
Holding in Top 10
–
Calls
$730K
Puts
$493K
Top Buyers
| 1 | +$129K | |
| 2 | +$60K | |
| 3 | +$57K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$54K |
| 5 |
OC
Oppenheimer & Co
New York
|
+$51K |
Top Sellers
| 1 | -$483K | |
| 2 | -$408K | |
| 3 | -$255K | |
| 4 |
Millennium Management
New York
|
-$198K |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$93.2K |